The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This comprehensive survey of people on Medicare, conducted in June and July 2004, assesses their attitudes toward the new Medicare drug law. This chartpack, issued in September 2004, presents additional analysis on the survey data, looking at key findings broken down by income group. Chartpack (.pdf)
This Policy Insight draws on the experiences of Medicare beneficiaries during Medicare’s annual enrollment period to consider whether consumers with health insurance coverage through the Affordable Care Act’s new marketplaces will shop for a better deal during their open enrollment season.
Addressing the cost of insulin continues to be at the forefront of policy discussions around prescription drugs. This analysis describes out-of-pocket spending on insulin products by Medicare beneficiaries enrolled in Part D drug plans, along with state-level use and spending data.
This brief describes the facts about actions taken under both the Trump and Biden Administrations related to capping insulin copayments for people with Medicare and explains the differences between their approaches.
Health News Index September/October, 2000 The September/October 2000 edition of the Kaiser Family Foundation/HarvardSchool of Public Health, Health News Index includes questions about how closely the public is following and how well they understand major health stories covered in the news during September, including stories about presidential candidates Al Gore and George W. Bush's prescription drug proposals. Every two months, Kaiser/Harvard issues a new index report. HNI September-October 2000 Topline/Survey MEDIA ADVISORY Download
Kaiser Health Poll Report Survey: Seniors' Early Experiences with the Medicare Prescription Drug Benefit This April 2006 tracking poll finds that most seniors enrolled in a Medicare drug plan are satisfied with their plan and are not having trouble getting the drugs they need. Most seniors enrolled in plans reported filling at least one prescription, and the vast majority of them -- more than 8 in 10 -- reported no problems getting their prescriptions filled.…
This paper, by Sara Rosenbaum, J.D., Director of the Center for Health Services Research and Policy at George Washington University, examines the procedures for resolving beneficiaries' grievances and appeals under the new Medicare drug benefit. It is one in a series commissioned by the Kaiser Family Foundation that analyzes issues surrounding the implementation of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) and the proposed regulations. Issue Brief (.pdf)
Implications of The Medicare Modernization Act For States: Observations from a Focus Group Discussion with Medicaid Directors This report summarizes a discussion with a group of state Medicaid officials about the impact of the Medicare prescription drug benefit on state Medicaid programs. Report (.pdf)
National Survey of Pharmacists 2006: Full Topline Results These toplines provide additional findings from a 2006 national survey of pharmacists on their views and experiences on a wide range of health care issues. Toplines (.pdf)
This report, written by Marilyn Moon and Matthew Storeygard of the Urban Institute, estimates the potential cost of targeting drug benefits to low-income Medicare beneficiaries and those with catastrophic drug expenses and discusses some of the key programmatic issues that could arise under this approach. The authors predict that a targeted and comprehensive drug benefit would likely help more than half of the 11.3 million low-income beneficiaries who lack drug coverage through Medicaid or an…
© 2026 KFF